Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02228174 · ClinicalTrials.gov registry record · NA

Sonography Guided Transcervical Ablation of Uterine Fibroids

A NA study of Menorrhagia, sponsored by Gynesonics.

Completed
Registry status
NA
Development phase
147
Enrollment target
20
Study locations

NCT02228174 is a NA study of Menorrhagia that has completed, run by Gynesonics. The registered enrollment target is 147 participants, below the 214-participant average among 10 other Menorrhagia trials with a reported enrollment target (31% lower). The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02228174, a NA study of Menorrhagia, has completed, sponsored by Gynesonics.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target
20
Study locations

Study Summary

The objective of this study is to establish the safety and effectiveness of the Sonata® System in the treatment of symptomatic uterine fibroids.

Conditions Studied

Interventions

  • DEVICE Intrauterine Ultrasound-Guided Radiofreq. Ablation System

Study Locations (20)

Florida

  • KO Clinical Research, LLC - Fort Lauderdale
  • Visions Clinical Research - Wellington

Pennsylvania

  • Drexel University - Philadelphia
  • Magee Women's Hospital - Pittsburgh

Texas

  • Baylor Research Institute - Fort Worth
  • Willowbend Health and Wellness Associates - Frisco

Arizona

  • Kelly H. Roy M.D. P.C. - Phoenix

Colorado

  • Advanced Women's Health Institute - Denver

Delaware

  • Christiana Care Health Services, Inc. - Newark

District of Columbia

  • George Washington University Hospital - Washington D.C.

Illinois

  • The Advanced Gynecologic Surgery Institute - Charles E. Miller, MD & Associates - Naperville

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2014-10
Est. Completion 2019-11
Phase NA

Sponsor

Gynesonics

1 total trials

What the Registry Record Tells You About NCT02228174

The ClinicalTrials.gov registry entry for NCT02228174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 10 other Menorrhagia trials with a reported enrollment target (31% lower). The listed sponsor is Gynesonics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Menorrhagia appearing as the primary indexed condition, and to 1 intervention - of which Intrauterine Ultrasound-Guided Radiofreq. Ablation System is the first listed.

NCT02228174 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Florida, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT02228174 about?

NCT02228174 is a clinical study titled "Sonography Guided Transcervical Ablation of Uterine Fibroids". The objective of this study is to establish the safety and effectiveness of the Sonata® System in the treatment of symptomatic uterine fibroids.

What is the current status of trial NCT02228174?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2014-10. Estimated completion is 2019-11.

What conditions does trial NCT02228174 study?

This clinical trial studies the following conditions: Menorrhagia.

What interventions are being tested in trial NCT02228174?

The interventions under investigation include: Intrauterine Ultrasound-Guided Radiofreq. Ablation System (DEVICE).

Who is sponsoring clinical trial NCT02228174?

This trial is sponsored by Gynesonics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02228174 being conducted?

This trial has 20 study locations across Arizona, Colorado, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menorrhagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.